Pure Global

Drug test for the qualitative detection of cells expressing the CD3 and/or CD4 antigens - Vietnam Registration 2402938ĐKLH/BYT-HTTB

Access comprehensive regulatory information for Drug test for the qualitative detection of cells expressing the CD3 and/or CD4 antigens in Vietnam's medical device market through Pure Global AI's free database. This Risk Class TTBYT Loại C medical device is registered under number 2402938ĐKLH/BYT-HTTB and manufactured by Immunotech SAS. The authorized representative in Vietnam is CÔNG TY TNHH KỸ THUẬT NAM PHƯƠNG.

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 300,000+ Vietnamese medical device registrations, helping global MedTech companies navigate Vietnam MOH regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
300,000+ Devices
2402938ĐKLH/BYT-HTTB
Registration Details
Vietnam MOH Registration: 2402938ĐKLH/BYT-HTTB
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing

Device Details

Drug test for the qualitative detection of cells expressing the CD3 and/or CD4 antigens
VN: Thuốc thử xét nghiệm định tính các tế bào biểu hiện kháng nguyên CD3 và/hoặc CD4
Risk Class TTBYT Loại C

Registration Details

2402938ĐKLH/BYT-HTTB

000.00.04.G18-231130-0021

CD3-FITC CD4-PE

A07733

Company Information

FRANCE

Beckman Coulter, Inc.

Technical Details

The CD3-FITC CD4-PE antibody cocktail, which combines fluorescent dye, enables the qualitative and quantitative determination of cells expressing the CD3 and/or CD4 antigens in human biological samples using flow cytometry.

Dates and Status

Oct 22, 2024